Related Experiment Videos

[Homocysteine, lipoprotein (a): risk factors for coronary heart disease]

A Laraqui1, N Bennouar, F Meggouh

  • 1Laboratoire de la ligue cardiovasculaire, Hôpital Ibn-sina, BP 1326, Rabat, Maroc.

Insights

Elevated homocysteine and lipoprotein Lp(a) levels are independent risk factors for coronary heart disease. This study found significant associations between higher levels of both markers and increased risk of significant coronary artery stenosis.

Area of Science:

  • Cardiovascular Medicine
  • Clinical Biochemistry
  • Medical Diagnostics

Context:

  • Coronary heart disease (CHD) is a leading cause of mortality worldwide.
  • Identifying novel risk factors is crucial for effective prevention strategies.
  • Hyperhomocysteinemia and elevated lipoprotein Lp(a) are implicated in cardiovascular pathology.

Purpose:

  • To investigate the association between plasma homocysteine and lipoprotein Lp(a) levels and the presence of coronary artery disease.
  • To determine if these markers act as independent risk factors for CHD.
  • To explore potential interactions between these markers and other known risk factors.

Summary:

  • This study analyzed 178 patients undergoing cardiac examination, measuring homocysteine and Lp(a) levels alongside traditional risk factors.
  • Significantly higher homocysteine and Lp(a) levels were observed in patients with significant coronary artery stenosis (cases) compared to controls.
  • Homocysteine and Lp(a) demonstrated strong, independent associations with CHD, with odds ratios indicating substantially increased risk at higher levels.

Impact:

  • The findings highlight homocysteine and Lp(a) as significant, independent risk factors for coronary heart disease.
  • This underscores the importance of monitoring these biomarkers in cardiovascular risk assessment.
  • Further research may elucidate mechanisms and inform targeted therapeutic interventions for CHD prevention.

Related Concept Videos